0
Research Letters |

Patient Information About Warfarin: An Assessment of Accuracy and Readability FREE

Artemis Diamantouros, RPh, MEd; William Bartle, PharmD; William Geerts, MD
[+] Author Affiliations

Author Affiliations: Departments of Pharmacy (Ms Diamantouros and Dr Bartle) and Medicine (Dr Geerts), Sunnybrook Health Sciences Centre, and Centre for Patient Safety (Dr Geerts), University of Toronto, Toronto, Ontario, Canada.


JAMA Intern Med. 2013;173(7):582-583. doi:10.1001/jamainternmed.2013.2781.
Text Size: A A A
Published online

Oral vitamin K antagonists, such as warfarin, are among the most commonly prescribed and potentially dangerous classes of medications.1 For many high-risk drugs, such as warfarin, there is a strong link between patient knowledge about the medication and their safe use.2 For warfarin, provision of high-quality education improves compliance, increases time in the therapeutic range, and leads to a reduction in complications.3 Patients are largely educated about warfarin through written information sheets provided by their pharmacies. Therefore, it is critical that these sheets are both accurate and understandable. The objectives of this study were to assess the content (accuracy and completeness) and reading level of patient education sheets (PES) about warfarin provided to patients by community pharmacies in Ontario, Canada, and by pharmaceutical producers of this high-risk drug.

A reference standard for content was developed based on a formal survey completed by 27 members of the Thrombosis Interest Group of Canada, a national group of thrombosis professionals. Five different warfarin PES (A, B, C, D, and E in the Table), distributed by 98% of the 3742 community pharmacies in Ontario (population, 12 million) were compared with the reference standard. The reading level was assessed using 2 standardized instruments, the SMOG and Flesch-Kincaid scales, and compared with the grade 5 to 6 reading level recommended for written patient information.4 Three patient booklets (X, Y, and Z in the Table), distributed by the commercial producers of warfarin, were also evaluated.

Table Graphic Jump LocationTable. Education Content and Reading Level of Warfarin PES Provided by Community Pharmacies and Information Booklets Provided by Warfarin Manufacturers

Expert consensus identified 50 items that were rated as “essential” or “important” for patient education about warfarin. On average, the PES included only 63% of the recommended essential or important knowledge items (range, 22%-72%) (Table). On average, the sheets had 24 missing items, including the importance of laboratory monitoring or reference to the variable and individualized dose of warfarin required by different patients. None of the PES mentioned specific target ranges for the international normalized ratio (INR) value or the consequences of having an INR result above or below the target range. Only 1 PES mentioned a safe amount of alcohol that could be consumed or the advice to avoid binge drinking. The others recommended patients to avoid alcohol, an example of incorrect information that could lead to unnecessary lifestyle restrictions and could have an impact on adherence. The average reading level of the PES was grade 10 using the Flesch-Kincaid scale (grade 9 to ≥12) and grade 12 using the SMOG scale (grade 12 to 14). The mean word-to-content ratio of the PES was 67:1, meaning that for every 67 words of text, 1 relevant item was stated. The longer the document, the more likely it was to cover important content.

The 3 pharmaceutical patient booklets were generally of better quality, including an average of 69% of the essential or important items (range, 50%-81%) and missing an average of 15 items. These booklets also contained fewer incorrect or misleading statements than those distributed by the community pharmacies. The reading level of these booklets was grade 8 using the Flesch-Kincaid scale (range, grade 8-9) and grade 11 using the SMOG scale (range, grade 11-12). Their mean word-to-content ratio was 68:1.

The findings of this study reveal that patients prescribed warfarin are very likely to receive information sheets from community pharmacies that contain only 63% of the content important for its safe use as well as statements that experts believe are misleading or incorrect. Comprehension of these sheets is also limited by a reading level approximately 5 or 6 grade levels above that recommended for health information.4 The readability results found in this study are consistent with previous research reviewing drug-related patient education brochures,5 where the mean reading level was grade 11. In a study of warfarin therapy, more than half of patients were unable to comprehend health-related words at levels beyond grade 8,6 and an increased risk of bleeding and nonadherence has been reported in patients with low literacy.7,8

The major limitation of this study is the absence of a gold standard for content of warfarin information; however, we relied on consensus from experts to create a reference standard. Although we reviewed PES distributed by Ontario pharmacies, the results are likely generalizable, since many community pharmacies across the country use information sheets obtained from the same small number of drug information databases. Since the drug information programs were produced by 5 different American and European software companies, our findings likely apply to warfarin PES at least across North America.

Appropriate and accurate information about warfarin is critical in helping patients make educated health care decisions. We suggest that standardization of the content of patient information about warfarin, developed with input from anticoagulation specialists and presented in a manner that is understandable by the majority of patients taking this medication, is an important patient safety priority. This approach to patient education must also be considered for other high-risk medications including the new oral anticoagulants and other medications with a narrow therapeutic index.

Correspondence: Dr Geerts, Thromboembolism Service, Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Room D674, Toronto, ON M4N 3M5, Canada (william.geerts@sunnybrook.ca).

Published Online: February 25, 2013. doi:10.1001/jamainternmed.2013.2781

Author Contributions:Study concept and design: Diamantouros, Bartle, and Geerts. Acquisition of data: Diamantouros. Analysis and interpretation of data: Diamantouros, Bartle, and Geerts. Drafting of the manuscript: Diamantouros and Geerts. Critical revision of the manuscript for important intellectual content: Diamantouros, Bartle, and Geerts. Statistical analysis: Diamantouros. Administrative, technical, and material support: Geerts. Study supervision: Bartle and Geerts.

Conflict of Interest Disclosures: Dr Bartle is the author of the warfarin information sheet for the Thrombosis Interest Group of Canada.

Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans.  N Engl J Med. 2011;365(21):2002-2012
PubMed   |  Link to Article
Tang EO, Lai CS, Lee KK, Wong RS, Cheng G, Chan TY. Relationship between patients' warfarin knowledge and anticoagulation control.  Ann Pharmacother. 2003;37(1):34-39
PubMed   |  Link to Article
Wofford JL, Wells MD, Singh S. Best strategies for patient education about anticoagulation with warfarin: a systematic review.  BMC Health Serv Res. 2008;8:40
PubMed   |  Link to Article
Estrada CA, Hryniewicz MM, Higgs VB, Collins C, Byrd JC. Anticoagulant patient information material is written at high readability levels.  Stroke. 2000;31(12):2966-2970
PubMed   |  Link to Article
Wolf MS, Davis TC, Shrank WH, Neuberger M, Parker RM. A critical review of FDA-approved medication guides.  Patient Educ Couns. 2006;62(3):316-322
PubMed   |  Link to Article
Wilson FL, Racine E, Tekieli V, Williams B. Literacy, readability and cultural barriers: critical factors to consider when educating older African Americans about anticoagulation therapy.  J Clin Nurs. 2003;12(2):275-282
PubMed   |  Link to Article
Diug B, Evans S, Lowthian J,  et al.  The unrecognized psychosocial factors contributing to bleeding risk in warfarin therapy.  Stroke. 2011;42(10):2866-2871
PubMed   |  Link to Article
Platt AB, Localio AR, Brensinger CM,  et al.  Risk factors for nonadherence to warfarin: results from the IN-RANGE study.  Pharmacoepidemiol Drug Saf. 2008;17(9):853-860
PubMed   |  Link to Article

Figures

Tables

Table Graphic Jump LocationTable. Education Content and Reading Level of Warfarin PES Provided by Community Pharmacies and Information Booklets Provided by Warfarin Manufacturers

References

Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans.  N Engl J Med. 2011;365(21):2002-2012
PubMed   |  Link to Article
Tang EO, Lai CS, Lee KK, Wong RS, Cheng G, Chan TY. Relationship between patients' warfarin knowledge and anticoagulation control.  Ann Pharmacother. 2003;37(1):34-39
PubMed   |  Link to Article
Wofford JL, Wells MD, Singh S. Best strategies for patient education about anticoagulation with warfarin: a systematic review.  BMC Health Serv Res. 2008;8:40
PubMed   |  Link to Article
Estrada CA, Hryniewicz MM, Higgs VB, Collins C, Byrd JC. Anticoagulant patient information material is written at high readability levels.  Stroke. 2000;31(12):2966-2970
PubMed   |  Link to Article
Wolf MS, Davis TC, Shrank WH, Neuberger M, Parker RM. A critical review of FDA-approved medication guides.  Patient Educ Couns. 2006;62(3):316-322
PubMed   |  Link to Article
Wilson FL, Racine E, Tekieli V, Williams B. Literacy, readability and cultural barriers: critical factors to consider when educating older African Americans about anticoagulation therapy.  J Clin Nurs. 2003;12(2):275-282
PubMed   |  Link to Article
Diug B, Evans S, Lowthian J,  et al.  The unrecognized psychosocial factors contributing to bleeding risk in warfarin therapy.  Stroke. 2011;42(10):2866-2871
PubMed   |  Link to Article
Platt AB, Localio AR, Brensinger CM,  et al.  Risk factors for nonadherence to warfarin: results from the IN-RANGE study.  Pharmacoepidemiol Drug Saf. 2008;17(9):853-860
PubMed   |  Link to Article

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 2

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Resolution

Users' Guides to the Medical Literature
Clinical Scenario